Economic Cost of Schizophrenia in a Nigerian Teaching Hospital.

Autor: Oloniniyi IO; Department of Mental Health, College of Health Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria.; Department of Mental Health, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria., Akinsulore A; Department of Mental Health, College of Health Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria.; Department of Mental Health, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria., Aloba OO; Department of Mental Health, College of Health Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria.; Department of Mental Health, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria., Mapayi BM; Department of Mental Health, College of Health Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria.; Department of Mental Health, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria., Oginni OA; Department of Mental Health, College of Health Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria.; Department of Mental Health, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria., Makanjuola R; Department of Mental Health, College of Health Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria.; Department of Mental Health, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria.
Jazyk: angličtina
Zdroj: Journal of neurosciences in rural practice [J Neurosci Rural Pract] 2019 Jan-Mar; Vol. 10 (1), pp. 39-47.
DOI: 10.4103/jnrp.jnrp_210_18
Abstrakt: Objective: This study evaluated the economic cost of schizophrenia in Nigerian patients and identified factors that influence cost.
Methods: A total of 100 participants with schizophrenia were assessed using the modified economic cost questionnaire, the mini-international neuropsychiatric interview, the positive and negative syndrome scale, the Liverpool University Neuroleptic side-effect rating scale, and the global assessment of functioning scale. Associations between sociodemographic characteristics, illness-related variables and direct, indirect, and total costs of schizophrenia were assessed.
Results: The average annual total, direct, and indirect costs of the treatment were $818.48, $349.59, and $468.89, respectively, per patient. The direct cost constituted 42.7%, while the indirect cost was 57.3% of the total costs of treatment. Hospitalization was the leading contributor to the direct cost, while productivity loss was a major component of the indirect cost.
Conclusion: Schizophrenia is an expensive disease in Nigeria, measures to reduce hospitalization could significantly reduce the cost of illness to the patient and their relatives.
Competing Interests: There are no conflicts of interest.
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje